Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases
Biochemistry Research International · 01.11.2023 · 2023 · 1-11
DOI: 10.1155/2023/5510874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemistry Research International, erschienen am 01.11.2023. Verfasst von Alireza Ebrahimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coenzyme Q10 (CoQ10), commonly known as ubiquinone, is a vitamin-like component generated in mitochondrial inner membranes. This molecule is detected broadly in different parts of the human body in various quantities. This molecule can be absorbed by the digestive system from various nutritional sources as supplements. CoQ10 exists in three states: in a of reduced form (ubiquinol), in a semiquinone radical form, and in oxidized ubiquinone form in different organs of the body, playing a crucial role in electron transportation and contributing to energy metabolism and oxygen utilization, especially in the musculoskeletal and nervous systems. Since the early 1980s, research about CoQ10 has become the interest for two reasons. First, CoQ10 deficiency has been found to have a link with cardiovascular, neurologic, and cancer disorders. Second, this molecule has an antioxidant and free-radical scavenger nature. Since then, several investigations have indicated that the drug may benefit patients with cardiovascular, neuromuscular, and neurodegenerative illnesses. CoQ10 may protect the neurological system from degeneration and degradation due to its antioxidant and energy-regulating activity in mitochondria. This agent has shown its efficacy in preventing and treating neurological diseases such as migraine, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Friedreich’s ataxia. This study reviews the literature to highlight this agent’s potential therapeutic effects in the mentioned neurological disorders.
Autor:innen und Institutionen
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Faculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
- Department of Medical Ethics, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Alireza Ebrahimi, Amirhossein Kamyab, Sahar Hosseini, Sedigheh Ebrahimi, Soheil Ashkani-Esfahani
Zitieren
APA
Ebrahimi, A., Kamyab, A., Hosseini, S., Ebrahimi, S., & Ashkani-Esfahani, S. (2023). Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases. Biochemistry Research International, 2023, 1-11. https://doi.org/10.1155/2023/5510874
Vancouver
Ebrahimi A, Kamyab A, Hosseini S, Ebrahimi S, Ashkani-Esfahani S. Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases. Biochemistry Research International. 2023;2023:1-11. doi:10.1155/2023/5510874
BibTeX
@article{Ebrahimi2023,
author = {Ebrahimi, Alireza and Kamyab, Amirhossein and Hosseini, Sahar and Ebrahimi, Sedigheh and Ashkani-Esfahani, Soheil},
title = {Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases},
journal = {Biochemistry Research International},
year = {2023},
volume = {2023},
pages = {1--11},
doi = {10.1155/2023/5510874}
}
EUVIMED